International journal of radiation oncology, biology, physics
-
Int. J. Radiat. Oncol. Biol. Phys. · Mar 1999
Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability.
Following the ICRU-50 recommendations, geometrical uncertainties in tumor position during radiotherapy treatments are generally included in the treatment planning by adding a margin to the clinical target volume (CTV) to yield the planning target volume (PTV). We have developed a method for automatic calculation of this margin. ⋯ A method has been developed for calculation of CTV-to-PTV margins based on the assumption that the CTV should be adequately irradiated with a high probability.
-
Int. J. Radiat. Oncol. Biol. Phys. · Mar 1999
The situation of radiation oncology training programs and their graduates in 1997.
In light of concerns about the job market, the American College of Radiology (ACR) studied the employment situation of 1997 radiation oncology graduates, and the status and plans of radiation oncology training programs. ⋯ Unemployment continues to be low, and one "softer" indicator, the job market perceptions of residency program directors, showed improvement.
-
Int. J. Radiat. Oncol. Biol. Phys. · Mar 1999
Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
To define patient, tumor, and treatment factors that influence the outcome of patients with FIGO Stage IIIB squamous cell carcinoma of the intact uterine cervix. ⋯ Aggressive use of ICRT, carefully balanced with pelvic EBRT, is necessary to achieve the best ratio between tumor control and complications for patients with FIGO Stage IIIB carcinoma of the cervix. In our experience, the highest DSS rates and the lowest complication rates were achieved with a combination of 40-45 Gy of EBRT combined with ICRT.
-
Int. J. Radiat. Oncol. Biol. Phys. · Mar 1999
Comment Letter Historical ArticleThe study of untreated syphilis in the negro male: regarding Brawley IJROBP 40:5-8; 1998.
-
Int. J. Radiat. Oncol. Biol. Phys. · Mar 1999
Randomized Controlled Trial Clinical TrialNo serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer.
To assess cardiac mortality, coronary artery disease, myocardial dysfunction, and valvular heart disease in women younger than 65 years of age, at least 10 years after adjuvant radiotherapy following mastectomy in early breast cancer. ⋯ Women younger than 50 years of age at the time of adjuvant radiotherapy following mastectomy in early breast cancer, had no serious cardiac sequelae 13 years (median) later, despite partly old-fashioned radiation techniques.